You are viewing: France Sleep Apnea Devices Market analysis
Part of: Sleep Apnea Devices Market (Global)

The France Sleep Apnea Devices Market was valued at $250.3 Million in 2025 and projected to reach to $422.5 Million by 2030, representing a compound annual growth rate of 7.8%. France's sleep apnea devices market is experiencing robust growth fueled by heightened awareness of sleep disorders and their health implications among both healthcare providers and patients.

France Sleep Apnea Devices Market Trends and Insights

  • This growth trajectory reflects increasing awareness of sleep apnea diagnosis and treatment across France, driven by rising healthcare expenditure and improved access to diagnostic technologies.
  • France's aging population and growing prevalence of obesity-related sleep disorders are key factors accelerating market expansion through 2030. The French sleep apnea devices market benefits from strong healthcare infrastructure and reimbursement policies that support both diagnostic and therapeutic device adoption.
  • France's emphasis on preventive care and chronic disease management has created favorable conditions for continuous positive airway pressure (CPAP) devices, oral appliances, and diagnostic equipment.
  • Between 2025 and 2030, France is expected to see increased penetration of home-based sleep testing solutions and advanced device technologies, positioning the country as a significant contributor to European market growth..

Key Market Statistics

  • CAGR (2025-2030) 7.8% CAGR
  • Market Size, 2025 ~USD 250.3 Million
  • Forecast, 2030 ~USD 422.5 Million
  • Country France

France Sleep Apnea Devices Market Overview

Market Valuation :

France's sleep apnea devices market is valued at USD 250.3 million in 2025, with strong growth momentum driven by increased diagnosis rates and healthcare investments across the country.

Aging Population Impact :

France's demographic shift toward an older population is significantly driving demand for sleep apnea diagnostic and therapeutic devices, as age is a primary risk factor for the condition.

Healthcare Infrastructure :

Improved access to diagnostic technologies and rising healthcare expenditure in France are enabling better detection and treatment of sleep apnea, supporting market expansion.

Growth Trajectory :

With a CAGR of 7.8% through 2030, France's market is projected to reach USD 422.5 million, outpacing the global growth rate of 7.6% and indicating strong regional demand.

France Sleep Apnea Devices Market Dynamics

  • The country's well-established healthcare system and increasing reimbursement coverage for sleep apnea treatments are creating favorable conditions for market expansion.
  • Rising diagnostic capabilities and technological advancements in portable and home-based monitoring devices are making treatment more accessible across French regions. Looking ahead to 2030, France's market is expected to benefit from continued aging demographics, enhanced clinical guidelines promoting early diagnosis, and growing adoption of digital health solutions.
  • Investment in sleep medicine research and development, coupled with improved patient education initiatives, will likely accelerate market penetration.
  • The competitive landscape will see increased innovation in CPAP alternatives and wearable monitoring technologies tailored to French healthcare standards..

Related Ecosystem

Medical Devices

Top Technologies
  • Polymerase Chain Reaction (PCR)
  • Magnetic Resonance Imaging (MRI)
  • Disposable Autoinjectors
  • Pulse Oximeters
  • Blood Pressure Monitors
Top Companies
  • Medtronic plc
  • Stryker Corporation
  • Abbott Laboratories
  • Becton, Dickinson and Company
  • JOHNSON & JOHNSON

    Key Takeaways

    • France's sleep apnea devices market is valued at USD 250.3 million in 2025 and will reach USD 422.5 million by 2030, growing at 7.8% CAGR.
    • France's aging demographic and rising obesity rates are primary drivers of increased sleep apnea diagnosis and device demand.
    • Strong healthcare reimbursement policies in France support adoption of CPAP devices, oral appliances, and home-based diagnostic solutions.
    • France is positioned as a key European market, with advanced healthcare infrastructure enabling rapid adoption of innovative sleep apnea technologies through 2030.

    Sleep Apnea Devices Market Report Scope

    Report Metric Details
    Base Year 2025
    Fastest Growing Segment ORAL APPLIANCES (Type)
    Forecast Period 2025–2030
    Growth Rate CAGR of 7.6% from 2025 to 2030
    Largest Segment THERAPEUTIC DEVICES (Product)
    Market Size Base Year (Billions) ~USD 6.95 (2025)
    Revenue Forecast (Billions) ~USD 10.03 (2030)
    Segments Covered Product, Type

    France Sleep Apnea Devices Market Report Segmentation

    2 segment dimensions are covered across the global market.

    By Product

    • Diagnostic Devices
    • Therapeutic Devices

    By Type

    • Accessories
    • Actigraphy Systems
    • Ambulatory Psg Devices
    • Apap Devices
    • Bpap Devices
    • Chin Restraints
    • Clinical Psg Devices
    • Communication Accessories
    • Cpap Devices
    • Cushions
    • Daytime-Nighttime Appliances
    • Facial Interfaces
    • Full-Face Masks
    • Home Sleep Testing Devices
    • Humidifier Accessories
    • Mandibular Advancement Devices
    • Masks
    • Nasal Masks
    • Nasal Pillow Masks
    • Oral Appliances
    • Other Accessories
    • Other Therapeutic Devices
    • Oximeters
    • Pap Devices
    • Power Accessories
    • Psg Devices
    • Sleep Screening Devices
    • Tongue-Retaining Devices
    • Transportation Accessories

    Target Audience

    • Medical Device Manufacturers : Manufacturers need France-specific market data to assess market opportunity, identify growth segments, and develop localized product strategies for sleep apnea devices in this high-growth European market.
    • Healthcare Investors & PE Firms : Investment professionals require detailed France market analysis to evaluate acquisition targets, assess portfolio company growth potential, and identify emerging opportunities in the sleep apnea sector.
    • Hospital & Clinic Administrators : Healthcare facility leaders need market insights to understand demand trends, plan equipment procurement budgets, and optimize sleep medicine service offerings for French patient populations.
    • Market Entry Consultants : Consulting firms advising international companies on France expansion require localized market data, competitive landscape analysis, and regulatory insights to guide client market entry strategies.
    • Healthcare Policy Makers : Government and regulatory bodies need comprehensive market analysis to inform reimbursement policies, healthcare resource allocation, and clinical guidelines for sleep apnea management in France.

    Key Companies in the France Sleep Apnea Devices Market

    CompanyHQOwnershipStrongest segments
    HENRY SCHEINUnited StatesPublic CompanyTherapeutic – Oral Appliances,Therapeutic – PAP Devices (CPAP, APAP, BPAP),Therapeutic – Masks and Consumables,
    ROSSMAX INTERNATIONAL LTDTaiwanPublic CompanyTherapeutic – PAP (CPAP, APAP, BPAP),Therapeutic – Oral Appliances,Therapeutic – Masks,
    SANOFISpainPublic CompanyTherapeutic – PAP (CPAP, APAP, BPAP),Therapeutic – Oral Appliances,Therapeutic – Masks,
    DANAHER CORPORATIONUnited StatesPublic CompanyTherapeutic – PAP (CPAP, APAP, BPAP),Therapeutic – Oral Appliances,Therapeutic – Masks,
    RESMEDUnited StatesPublic CompanyTherapeutic – PAP devices (CPAP, APAP, BPAP),Therapeutic – Masks and interfaces,Therapeutic – Oral appliances,
    KONINKLIJKE PHILIPS N.V.NetherlandsPublic CompanyTherapeutic – PAP (CPAP, APAP, BPAP),Therapeutic – Masks and Interfaces,Therapeutic – Oral Appliances,
    FISHER & PAYKEL HEALTHCARE LIMITEDNew ZealandPublic CompanyTherapeutic – PAP devices (CPAP, APAP, BPAP),Therapeutic – Masks and interfaces,Therapeutic – Oral appliances,
    INSPIRE MEDICAL SYSTEMS, INC.United StatesPublic CompanyTherapeutic – Neurostimulation System (competes with PAP/Oral Appliances/Masks),Diagnostic-Linked Services (competes with PSG/Home Sleep Testing/Oximeter adjacencies),
    SOMNOMEDAustraliaPublic CompanyTherapeutic – Oral Appliances (SomnoDent portfolio, SomMorning Repositioner, SomnoBrux),Adjacencies – Cleaning and maintenance (SomTabs) and related accessories,Non-OSA dental protection (SomnoBrux-only use cases),
    COMPUMEDICS LIMITEDAustraliaPublic CompanyDiagnostic – PSG Systems (lab-based and ambulatory),Diagnostic – Home Sleep Testing & Wearables,Diagnostic – Oximetry and Ancillary Monitoring,
    BMCUnited StatesPrivate CompanyTherapeutic Devices (PAP, Oral Appliances, Masks),Diagnostic Devices (PSG, Home Sleep Testing, Oximeter),Healthcare IT / Workflow Enablement for Sleep Care,
    PROSOMNUS SLEEP TECHNOLOGIESUnited StatesPrivate CompanyTherapeutic – Oral Appliances,Therapeutic – PAP (CPAP, APAP, BPAP),Therapeutic – Masks,

    HENRY SCHEIN

    Henry Schein is a publicly traded United States company founded in 1932 with 25,000 employees.

    ROSSMAX INTERNATIONAL LTD

    Rossmax International Ltd is a publicly traded company based in Taiwan, founded in 1988.

    SANOFI

    Sanofi is a publicly traded pharmaceutical company based in Spain, founded in 1994 with 74,846 employees.

    DANAHER CORPORATION

    Danaher Corporation is a publicly traded United States company founded in 1969 with 59,000 employees.

    RESMED

    ResMed is a publicly traded United States company founded in 1989 with 10,600 employees.

    KONINKLIJKE PHILIPS N.V.

    Koninklijke Philips N.V. is a publicly traded Dutch company founded in 1891 with 64,317 employees.

    FISHER & PAYKEL HEALTHCARE LIMITED

    Fisher & Paykel Healthcare Limited is a publicly traded New Zealand company founded in 1934 with 7,396 employees.

    INSPIRE MEDICAL SYSTEMS, INC.

    Inspire Medical Systems, Inc. is a publicly traded United States company founded in 2007 with 1,333 employees.

    SOMNOMED

    SomnoMed is a publicly traded Australian company founded in 1987 with 300 employees.

    COMPUMEDICS LIMITED

    Compumedics Limited is a publicly traded Australian company founded in 1987 with 175 employees.

    BMC

    BMC is a United States-based private company founded in 1980 with 6,700 employees.

    PROSOMNUS SLEEP TECHNOLOGIES

    ProSomnus Sleep Technologies is a United States-based private company founded in 2016 with 136 employees.

    Reasons to Buy this Report

    • Precise Market Sizing : Access validated market valuations specific to France (USD 250.3M in 2025) with detailed forecasts through 2030, enabling accurate budgeting and investment planning for French market entry.
    • Regional Growth Intelligence : Understand France's 7.8% CAGR outperformance versus global 7.6%, identifying unique growth drivers including aging demographics and healthcare infrastructure improvements specific to the French market.
    • Competitive Positioning : Benchmark your organization against market trends in France's sleep apnea sector, including diagnostic technology adoption rates and treatment accessibility patterns unique to French healthcare systems.
    • Strategic Market Entry : Leverage France-specific insights on reimbursement policies, regulatory requirements, and patient demographics to develop targeted go-to-market strategies and localized product positioning.
    • Investment Decision Support : Make data-driven decisions on resource allocation, partnership development, and expansion timelines in France with comprehensive market analysis and forward-looking projections through 2030.

    Frequently asked questions

    What is the current market size of sleep apnea devices in France?

    France's sleep apnea devices market is valued at USD 250.3 million in 2025.

    What is the projected market size for sleep apnea devices in France by 2030?

    France's sleep apnea devices market is projected to reach USD 422.5 million by 2030.

    What is the growth rate of the sleep apnea devices market in France?

    France's sleep apnea devices market is expected to grow at a compound annual growth rate (CAGR) of 7.8% from 2025 to 2030.

    What factors are driving growth in France's sleep apnea devices market?

    Key growth drivers in France include an aging population, rising obesity rates, increased healthcare awareness, strong reimbursement policies, and improved access to diagnostic technologies.

    Which device types are most prevalent in France's sleep apnea market?

    France's market is dominated by continuous positive airway pressure (CPAP) devices, oral appliances, and home-based sleep diagnostic equipment, supported by favorable healthcare policies.

    RESEARCH METHODOLOGY

    The study analyzes key market dynamics, such as drivers, opportunities, restraints, challenges, and key player strategies. To track company developments such as acquisitions, product launches and approvals, expansions, agreements, and partnerships of the leading players, the competitive landscape of the sleep apnea devices market is analyzed to evaluate market players on various parameters within the broad categories of business and product strategy. Top-down and bottom-up approaches were used to estimate the market size. The market breakdown and data triangulation were used to estimate the market size of segments and subsegments.

    The four steps involved in estimating the market size are

    Secondary Research

    In the secondary research process, various secondary sources such as annual reports, press releases & investor presentations of companies, white papers, certified publications, articles by recognized authors, gold-standard & silver-standard websites, regulatory bodies, and databases (such as D&B Hoovers, Bloomberg Business, and Factiva) were referred to identify and collect information for this study.

    Primary Research

    In the primary research process, various supply and demand sources were interviewed to obtain qualitative and quantitative information for this report. Primary sources were mainly industry experts from the core and related industries and preferred suppliers, manufacturers, distributors, service providers, technology developers, researchers, and organizations related to all segments of this industry’s value chain. In-depth interviews were conducted with primary respondents, including key industry participants, subject-matter experts, C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative and quantitative information and assess prospects.

    The following is a breakdown of the primary respondents:

    Sleep Apnea Devices Market

    Note 1: Others include sales, marketing, and product managers.

    Note 2: Companies are classified into tiers based on their total revenues. As of 2022/2023, Tier 1 = >USD 1 million, Tier 2 = USD 500 million to USD 1 billion, and Tier 3 = < USD 500 million.

    To know about the assumptions considered for the study, download the pdf brochure

    COMPANY NAME DESIGNATION
    SOMNOmedcis AG (Germany) Country Manager
    ResMed (US) Regional Sales Manager

    Market Size Estimation

    Both top-down and bottom-up approaches were used to estimate and validate the total size of sleep apnea devices in the market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

    • The key players in the industry have been identified through extensive secondary research
    • Primary and secondary research has determined the revenues generated by leading players operating in the sleep apnea devices market.
    • All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources.

    Global Sleep Apnea Devices Market Size: Bottom-up and Top-down Approach

    Sleep Apnea Devices Market

    Data Triangulation

    After arriving at the overall market size by applying the abovementioned process, the total market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.

    Market Definition

    Sleep apnea is a prevalent sleep disorder that is frequently undiagnosed, yet it poses significant health risks. This condition is characterized by intermittent cessation of breathing, which can last from several seconds to minutes, or by irregular breathing patterns. The most predominant form is obstructive sleep apnea (OSA), where anatomical or physiological obstructions impede airflow during sleep. Continuous positive airway pressure (CPAP) devices are commonly used to deliver air at elevated pressure through the nasal passages, effectively counteracting upper airway obstructions and facilitating normal respiration. These interventions are crucial for mitigating the associated morbidities linked with untreated sleep apnea.

    Stakeholders

    • Senior Management
    • Sleep Laboratories, Clinics, & Hospitals
    • Home Care Settings
    • Academic & research institutes
    • Finance/Procurement Department
    • R&D Department

    Report Objectives

    • To define, describe, segment, and forecast the global sleep apnea devices market by product, age group, gender, end user, and region
    • To provide detailed information regarding the major factors influencing the market growth (such as drivers, restraints, opportunities, challenges, and trends)
    • To analyze the micromarkets with respect to individual growth trends, prospects, and contributions to the overall sleep apnea devices market
    • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
    • To forecast the size of the market segments with respect to five regions—North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa.
    • To profile the key players and comprehensively analyze their product portfolios, market positions, and core competencies
    • To benchmark players within the market using the proprietary Company Evaluation Matrix framework, which analyzes market players on various parameters within the broad categories of business and product excellence

    Get the Full Sleep Apnea Devices Market Report

    Full forecast, segment splits, and company analysis for all Sleep Apnea Devices Market.

    Need a Tailored Report?

    Customize this report to your needs

    Get 10% FREE Customization

    Customize This Report
    Fact checked
    DMCA.com Protection Status